Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19 (vol 61, pg 973, 2022)

被引:0
|
作者
Smeets, Tim J. L. [1 ]
Valkenburg, Abraham J. [2 ]
van der Jagt, Mathieu [2 ]
Koch, Birgit C. P. [1 ]
Endeman, Henrik [2 ]
Gommers, Diederik A. M. P. J. [2 ]
Sassen, Sebastian D. T. [1 ]
Hunfeld, Nicole G. M. [1 ,2 ]
机构
[1] Erasmus MC Univ Med Ctr Rotterdam, Dept Hosp Pharm, Doctor Molewaterpl 40,POB 2040, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus MC Univ Med Ctr Rotterdam, Dept Intens Care Adults, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands
关键词
D O I
10.1007/s40262-024-01389-w
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1065 / 1065
页数:1
相关论文
共 50 条
  • [1] Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19
    Smeets, Tim J. L.
    Valkenburg, Abraham J.
    van der Jagt, Mathieu
    Koch, Birgit C. P.
    Endeman, Henrik
    Gommers, Diederik A. M. P. J.
    Sassen, Sebastian D. T.
    Hunfeld, Nicole G. M.
    CLINICAL PHARMACOKINETICS, 2022, 61 (07) : 973 - 983
  • [2] Management of Critically Ill Adults With COVID-19
    Poston, Jason T.
    Patel, Bhakti K.
    Davis, Andrew M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18): : 1839 - 1841
  • [3] Case Report: Myopathy in Critically Ill COVID-19 Patients: A Consequence of Hyperinflammation?
    Versace, Viviana
    Sebastianelli, Luca
    Ferrazzoli, Davide
    Saltuari, Leopold
    Kofler, Markus
    Loscher, Wolfgang
    Uncini, Antonino
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [4] Assessment of Admission COVID-19 Associated Hyperinflammation Syndrome Score in Critically-Ill COVID-19 Patients
    Yildirim, Mehmet
    Halacli, Burcin
    Yuce, Deniz
    Gunegul, Yunus
    Ersoy, Ebru Ortac
    Topeli, Arzu
    JOURNAL OF INTENSIVE CARE MEDICINE, 2022, : 70 - 77
  • [5] PHARMACOKINETIC INFLUENCE OF TOCILIZUMAB ON MIDAZOLAM IN CRITICALLY ILL PATIENTS WITH COVID-19
    Mefford, Breanne
    Donaldson, Chris
    Bissell, Brittany
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 114 - 114
  • [6] Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19 (vol 84, pg 913, 2020)
    Yu, Bo
    Li, Chenze
    Chen, Peng
    Zhou, Ning
    Wang, Luyun
    Li, Jia
    Jiang, Hualiang
    Wang, Dao-Wen
    SCIENCE CHINA-LIFE SCIENCES, 2020, 63 (10) : 1617 - 1618
  • [7] Tissue Plasminogen Activator in Critically Ill Adults with COVID-19
    Douin, David J.
    Shaefi, Shahzad
    Brenner, Samantha K.
    Gupta, Shruti
    Park, Isabel
    Wright, Franklin L.
    Mathews, Kusum S.
    Chan, Lili
    Al-Samkari, Hanny
    Orfanos, Sarah
    Radbel, Jared
    Leaf, David E.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (11) : 1917 - 1921
  • [8] Religion, Islam, and Compliance with COVID-19 Best Practices (vol 61, pg 4155, 2022)
    Dajani, Rana
    Coetsee, Marilie
    Al-Tabba, Amal
    Al-Hussaini, Maysa
    JOURNAL OF RELIGION & HEALTH, 2023, 62 (04): : 2997 - 2998
  • [9] Nutrition guidelines for critically ill adults admitted with COVID-19: Is there consensus?
    Chapple, Lee-anne S.
    Tatucu-Babet, Oana A.
    Lambell, Kate J.
    Fetterplace, Kate
    Ridley, Emma J.
    CLINICAL NUTRITION ESPEN, 2021, 44 : 69 - 77
  • [10] The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients (vol 190, pg 1317, 2021)
    Boyd, Sean
    Martin-Loeches, Ignacio
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (02) : 965 - 965